2024 Recipients of NMD4C and MDC Neuromuscular Fellowship Funding Competition
Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2024 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in NMD research and clinical fellowships in neuromuscular medicine and electromyography! NMD4C and MDC are committed to empowering the next generation of early-career researchers and clinicians in building successful careers in neuromuscular disease (NMD) research and clinical practice to improve neuromuscular care, research, treatment, and health outcomes for all Canadians.
The 2024 competition provides salary support for two early-career scientists to conduct postdoctoral studies in laboratories focused on NMD research, and three early-career neurologists to participate in neuromuscular medicine and electromyography training programs. Successful applicants receive $40 000 in funding over a one-year period for postdoctoral fellowships, and $80 000 in funding over a one-year period for clinical fellowships. Since 2022, this competition has provided $1 million in funding to support neuromuscular postdoctoral researchers and clinical fellows in Canada, made possible by generous supporters of MDC, with one clinical fellow each year by the Canadian Society for Clinical Neurophysiologists.
This competition involves an extensive review by leading Canadian neuromuscular researchers and clinicians to ensure the top-ranked candidates are selected for this funding opportunity. From the entire neuromuscular community, congratulations to all 2024 recipients!
Postdoctoral Fellowship Recipients:
Dr. Yassine Ouhaddi Centre de recherche du CHU Sainte-Justine, Montreal, QC
Learn more about the 2024 postdoctoral fellows and their research projects.
Clinical Fellowship Recipients
Dr. Yiu-Chia Chang University of Western Ontario, London, ON
Dr. Mark Krongold University of British Columbia, Vancouver, BC
Dr. Bram De Wel University of Calgary, Calgary, AB
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.